UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 16

of 'Treatment of locoregionally advanced (stage III and IV) head and neck cancer: The oral cavity'

16
TI
Lip cancer treatment with high dose rate brachytherapy.
AU
Guinot JL, Arribas L, Chust ML, Mengual JL, García Miragall E, Carrascosa M, Escolar PP, Crispín V, Guardino C
SO
Radiother Oncol. 2003;69(1):113.
 
We present 39 patients with lip carcinoma treated with HDR, (needles) with 5-5.5 Gy per 8-10 fractions b.i.d. (total dose 40.5-45 Gy). Three-year cause-specific survival and local control are 91 and 88% (95% T1-2, 74% T4, p<0.05). Acute and chronic reactions are like LDR cases. We think that HDR results are equivalent to LDR.
AD
Department of Radiotherapy, Fundación Instituto Valenciano de Oncología (IVO), C/Profesor Beltrán Báguena 9, Valencia 46006, Spain.
PMID